https://stock.noler.com/us/stock/effector-therapeutics-inc https://stock.noler.com/us/stock/effector-therapeutics-inc/13f-holdings-corporate-securities https://stock.noler.com/us/stock/effector-therapeutics-inc/accounts-payable https://stock.noler.com/us/stock/effector-therapeutics-inc/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/effector-therapeutics-inc/accrued-income-taxes-current https://stock.noler.com/us/stock/effector-therapeutics-inc/accrued-liabilities-and-other-liabilities https://stock.noler.com/us/stock/effector-therapeutics-inc/accrued-liabilities-current https://stock.noler.com/us/stock/effector-therapeutics-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/effector-therapeutics-inc/accumulated-depreciation https://stock.noler.com/us/stock/effector-therapeutics-inc/additional-paid-in-capital https://stock.noler.com/us/stock/effector-therapeutics-inc/adjustment-for-long-term-intercompany-transactions-gross-of-tax https://stock.noler.com/us/stock/effector-therapeutics-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/effector-therapeutics-inc/amended-reports https://stock.noler.com/us/stock/effector-therapeutics-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/effector-therapeutics-inc/aoci https://stock.noler.com/us/stock/effector-therapeutics-inc/assets-held-in-trust-noncurrent https://stock.noler.com/us/stock/effector-therapeutics-inc/auditor https://stock.noler.com/us/stock/effector-therapeutics-inc/authorized-dilution https://stock.noler.com/us/stock/effector-therapeutics-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/effector-therapeutics-inc/available-for-sale-debt-gain-loss https://stock.noler.com/us/stock/effector-therapeutics-inc/available-for-sale-debt-gross-unrealized-gain https://stock.noler.com/us/stock/effector-therapeutics-inc/available-for-sale-debt-gross-unrealized-loss https://stock.noler.com/us/stock/effector-therapeutics-inc/basic-shares https://stock.noler.com/us/stock/effector-therapeutics-inc/beta https://stock.noler.com/us/stock/effector-therapeutics-inc/borrowing-debt https://stock.noler.com/us/stock/effector-therapeutics-inc/business-acquisition-cost-of-acquired-entity-transaction-costs https://stock.noler.com/us/stock/effector-therapeutics-inc/buybacks-repurchase-programs https://stock.noler.com/us/stock/effector-therapeutics-inc/capitalized-exploratory-well-cost-charged-to-expense https://stock.noler.com/us/stock/effector-therapeutics-inc/cash https://stock.noler.com/us/stock/effector-therapeutics-inc/cash-and-equivalents https://stock.noler.com/us/stock/effector-therapeutics-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/effector-therapeutics-inc/cash-and-restricted-cash-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/effector-therapeutics-inc/cash-and-securities https://stock.noler.com/us/stock/effector-therapeutics-inc/cash-cash-equivalents-and-short-term-investments https://stock.noler.com/us/stock/effector-therapeutics-inc/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/effector-therapeutics-inc/cash-fdic-insured-amount https://stock.noler.com/us/stock/effector-therapeutics-inc/cash-flow-breakdown https://stock.noler.com/us/stock/effector-therapeutics-inc/change-in-unrealized-gain-loss-on-fair-value-hedging-instruments https://stock.noler.com/us/stock/effector-therapeutics-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/effector-therapeutics-inc/class-of-warrant-or-right-number-of-securities-called-by-each-warrant-or-right https://stock.noler.com/us/stock/effector-therapeutics-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/effector-therapeutics-inc/clinical-trials https://stock.noler.com/us/stock/effector-therapeutics-inc/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/effector-therapeutics-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/effector-therapeutics-inc/common-stock-value https://stock.noler.com/us/stock/effector-therapeutics-inc/comprehensive-income https://stock.noler.com/us/stock/effector-therapeutics-inc/congressional-trades https://stock.noler.com/us/stock/effector-therapeutics-inc/convertible-preferred-stock-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/effector-therapeutics-inc/convertible-securities-outstanding https://stock.noler.com/us/stock/effector-therapeutics-inc/convertible-securities-retired https://stock.noler.com/us/stock/effector-therapeutics-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/effector-therapeutics-inc/current-assets https://stock.noler.com/us/stock/effector-therapeutics-inc/current-liabilities https://stock.noler.com/us/stock/effector-therapeutics-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/effector-therapeutics-inc/customer-breakdown https://stock.noler.com/us/stock/effector-therapeutics-inc/debt-and-obligation-disclosures https://stock.noler.com/us/stock/effector-therapeutics-inc/debt-carrying-amount https://stock.noler.com/us/stock/effector-therapeutics-inc/debt-interest-rate-effective-percentage https://stock.noler.com/us/stock/effector-therapeutics-inc/debt-issued https://stock.noler.com/us/stock/effector-therapeutics-inc/debt-maturing-in-year-five https://stock.noler.com/us/stock/effector-therapeutics-inc/debt-maturing-in-year-four https://stock.noler.com/us/stock/effector-therapeutics-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/effector-therapeutics-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/effector-therapeutics-inc/debt-repaid https://stock.noler.com/us/stock/effector-therapeutics-inc/debt-unamortized-discount https://stock.noler.com/us/stock/effector-therapeutics-inc/deferred-policy-acquisition-cost-amortization-expense-net-investment-gains-losses https://stock.noler.com/us/stock/effector-therapeutics-inc/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/effector-therapeutics-inc/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/effector-therapeutics-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/effector-therapeutics-inc/deferred-tax-assets-in-process-research-and-development https://stock.noler.com/us/stock/effector-therapeutics-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/effector-therapeutics-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/effector-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/effector-therapeutics-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/effector-therapeutics-inc/deferred-tax-assets-tax-credit-carryforwards-other https://stock.noler.com/us/stock/effector-therapeutics-inc/deferred-tax-assets-tax-deferred-expense-compensation-and-benefits-employee-compensation https://stock.noler.com/us/stock/effector-therapeutics-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/effector-therapeutics-inc/deferred-tax-liabilities https://stock.noler.com/us/stock/effector-therapeutics-inc/defined-contribution-plan-cost-recognized https://stock.noler.com/us/stock/effector-therapeutics-inc/depreciation-and-amortization https://stock.noler.com/us/stock/effector-therapeutics-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/effector-therapeutics-inc/derivative-liabilities-current https://stock.noler.com/us/stock/effector-therapeutics-inc/diluted-shares https://stock.noler.com/us/stock/effector-therapeutics-inc/dilutive-shares https://stock.noler.com/us/stock/effector-therapeutics-inc/disposal-group-not-discontinued-operation-gain-loss-on-disposal https://stock.noler.com/us/stock/effector-therapeutics-inc/dividend-safety https://stock.noler.com/us/stock/effector-therapeutics-inc/due-from-related-parties https://stock.noler.com/us/stock/effector-therapeutics-inc/earnings-and-revenue-growth https://stock.noler.com/us/stock/effector-therapeutics-inc/ebitda https://stock.noler.com/us/stock/effector-therapeutics-inc/effective-tax-rate https://stock.noler.com/us/stock/effector-therapeutics-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/effector-therapeutics-inc/employee-stock-ownership-plan-esop-compensation-expense https://stock.noler.com/us/stock/effector-therapeutics-inc/eps https://stock.noler.com/us/stock/effector-therapeutics-inc/eps-basic https://stock.noler.com/us/stock/effector-therapeutics-inc/executive-pay-measures https://stock.noler.com/us/stock/effector-therapeutics-inc/executive-pay-other https://stock.noler.com/us/stock/effector-therapeutics-inc/executive-pay-pvp https://stock.noler.com/us/stock/effector-therapeutics-inc/executive-pay-trading-arrangements https://stock.noler.com/us/stock/effector-therapeutics-inc/executive-salary-before-2006 https://stock.noler.com/us/stock/effector-therapeutics-inc/executive-salary-board https://stock.noler.com/us/stock/effector-therapeutics-inc/executive-salary-equity-awards https://stock.noler.com/us/stock/effector-therapeutics-inc/executive-salary-officers https://stock.noler.com/us/stock/effector-therapeutics-inc/executive-salary-other-compensation https://stock.noler.com/us/stock/effector-therapeutics-inc/executive-salary-other-mentions https://stock.noler.com/us/stock/effector-therapeutics-inc/executive-salary-pay-ratio https://stock.noler.com/us/stock/effector-therapeutics-inc/executive-salary-relatives https://stock.noler.com/us/stock/effector-therapeutics-inc/fails-to-deliver https://stock.noler.com/us/stock/effector-therapeutics-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/effector-therapeutics-inc/fair-value-net-derivative-asset-liability-change-in-unrealized-gain-loss https://stock.noler.com/us/stock/effector-therapeutics-inc/fair-value-net-derivative-asset-liability-unobservable-inputs-reconciliation-issues https://stock.noler.com/us/stock/effector-therapeutics-inc/fair-value-net-derivative-asset-liability-unobservable-inputs-reconciliation-transfers-net https://stock.noler.com/us/stock/effector-therapeutics-inc/fair-value-net-derivative-asset-liability-with-unobservable-inputs https://stock.noler.com/us/stock/effector-therapeutics-inc/federal-income-tax-expense-benefit https://stock.noler.com/us/stock/effector-therapeutics-inc/financing-cash-flow https://stock.noler.com/us/stock/effector-therapeutics-inc/free-cash-flow https://stock.noler.com/us/stock/effector-therapeutics-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/effector-therapeutics-inc/gains-losses-on-sales-of-assets https://stock.noler.com/us/stock/effector-therapeutics-inc/general-and-administrative-expense https://stock.noler.com/us/stock/effector-therapeutics-inc/gross-margin https://stock.noler.com/us/stock/effector-therapeutics-inc/holders-breakdown https://stock.noler.com/us/stock/effector-therapeutics-inc/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/effector-therapeutics-inc/income-loss-from-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/effector-therapeutics-inc/income-tax https://stock.noler.com/us/stock/effector-therapeutics-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/effector-therapeutics-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/effector-therapeutics-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/effector-therapeutics-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/effector-therapeutics-inc/increase-decrease-in-contract-with-customer-liability https://stock.noler.com/us/stock/effector-therapeutics-inc/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/effector-therapeutics-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/effector-therapeutics-inc/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/effector-therapeutics-inc/increase-decrease-in-prepaid-expenses-other https://stock.noler.com/us/stock/effector-therapeutics-inc/incremental-common-shares-attributable-to-share-based-payment-arrangements https://stock.noler.com/us/stock/effector-therapeutics-inc/insider-holders https://stock.noler.com/us/stock/effector-therapeutics-inc/insider-transactions-corporate-securities https://stock.noler.com/us/stock/effector-therapeutics-inc/insider-transactions-other https://stock.noler.com/us/stock/effector-therapeutics-inc/insider-transactions-preferred https://stock.noler.com/us/stock/effector-therapeutics-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/effector-therapeutics-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/effector-therapeutics-inc/insider-transactions-swaps-forwards-futures https://stock.noler.com/us/stock/effector-therapeutics-inc/insider-transactions-warrants https://stock.noler.com/us/stock/effector-therapeutics-inc/institutional-holders https://stock.noler.com/us/stock/effector-therapeutics-inc/interest-and-dividends-payable-current https://stock.noler.com/us/stock/effector-therapeutics-inc/interest-expense https://stock.noler.com/us/stock/effector-therapeutics-inc/interest-income-other https://stock.noler.com/us/stock/effector-therapeutics-inc/interest-paid-net https://stock.noler.com/us/stock/effector-therapeutics-inc/interest-payable-current https://stock.noler.com/us/stock/effector-therapeutics-inc/investing-cash-flow https://stock.noler.com/us/stock/effector-therapeutics-inc/investment-income-interest https://stock.noler.com/us/stock/effector-therapeutics-inc/investment-income-net-amortization-of-discount-and-premium https://stock.noler.com/us/stock/effector-therapeutics-inc/iran-activity-notices https://stock.noler.com/us/stock/effector-therapeutics-inc/late-filing-notices https://stock.noler.com/us/stock/effector-therapeutics-inc/lawsuits-defendant https://stock.noler.com/us/stock/effector-therapeutics-inc/lawsuits-plaintiff https://stock.noler.com/us/stock/effector-therapeutics-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/effector-therapeutics-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/effector-therapeutics-inc/liabilities-assumed https://stock.noler.com/us/stock/effector-therapeutics-inc/long-term-debt https://stock.noler.com/us/stock/effector-therapeutics-inc/major-holders https://stock.noler.com/us/stock/effector-therapeutics-inc/material-contracts https://stock.noler.com/us/stock/effector-therapeutics-inc/mentioned-by-other https://stock.noler.com/us/stock/effector-therapeutics-inc/minimum-net-worth-required-for-compliance https://stock.noler.com/us/stock/effector-therapeutics-inc/mutual-fund-holders https://stock.noler.com/us/stock/effector-therapeutics-inc/net-change-in-cash https://stock.noler.com/us/stock/effector-therapeutics-inc/net-income https://stock.noler.com/us/stock/effector-therapeutics-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/effector-therapeutics-inc/net-income-loss-available-to-common-stockholders-diluted https://stock.noler.com/us/stock/effector-therapeutics-inc/news https://stock.noler.com/us/stock/effector-therapeutics-inc/notes-payable-current https://stock.noler.com/us/stock/effector-therapeutics-inc/number-of-operating-segments https://stock.noler.com/us/stock/effector-therapeutics-inc/obligation-breakdown https://stock.noler.com/us/stock/effector-therapeutics-inc/oci-tax https://stock.noler.com/us/stock/effector-therapeutics-inc/operating-cash-flow https://stock.noler.com/us/stock/effector-therapeutics-inc/operating-costs-and-expenses https://stock.noler.com/us/stock/effector-therapeutics-inc/operating-expenses https://stock.noler.com/us/stock/effector-therapeutics-inc/operating-income https://stock.noler.com/us/stock/effector-therapeutics-inc/operating-lease-assets https://stock.noler.com/us/stock/effector-therapeutics-inc/operating-lease-cost https://stock.noler.com/us/stock/effector-therapeutics-inc/operating-lease-lease-income-lease-payments https://stock.noler.com/us/stock/effector-therapeutics-inc/operating-lease-liability https://stock.noler.com/us/stock/effector-therapeutics-inc/operating-lease-liability-current https://stock.noler.com/us/stock/effector-therapeutics-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/effector-therapeutics-inc/operating-lease-payments https://stock.noler.com/us/stock/effector-therapeutics-inc/operating-lease-payments-due https://stock.noler.com/us/stock/effector-therapeutics-inc/operating-lease-payments-due-in-rolling-year-three https://stock.noler.com/us/stock/effector-therapeutics-inc/operating-lease-payments-due-in-rolling-year-two https://stock.noler.com/us/stock/effector-therapeutics-inc/operating-lease-payments-due-next-rolling-twelve-months https://stock.noler.com/us/stock/effector-therapeutics-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/effector-therapeutics-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/effector-therapeutics-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/effector-therapeutics-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/effector-therapeutics-inc/operating-leases-future-minimum-payments-receivable-current https://stock.noler.com/us/stock/effector-therapeutics-inc/operating-margin https://stock.noler.com/us/stock/effector-therapeutics-inc/other https://stock.noler.com/us/stock/effector-therapeutics-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/effector-therapeutics-inc/other-accrued-liabilities-noncurrent https://stock.noler.com/us/stock/effector-therapeutics-inc/other-assets https://stock.noler.com/us/stock/effector-therapeutics-inc/other-income https://stock.noler.com/us/stock/effector-therapeutics-inc/other-noncash-expense https://stock.noler.com/us/stock/effector-therapeutics-inc/other-noncurrent-assets https://stock.noler.com/us/stock/effector-therapeutics-inc/other-nonoperating-expense https://stock.noler.com/us/stock/effector-therapeutics-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/effector-therapeutics-inc/other-tax-expense-benefit https://stock.noler.com/us/stock/effector-therapeutics-inc/outstanding-bonds https://stock.noler.com/us/stock/effector-therapeutics-inc/outstanding-bonds-foreign https://stock.noler.com/us/stock/effector-therapeutics-inc/outstanding-bonds-matured https://stock.noler.com/us/stock/effector-therapeutics-inc/outstanding-bonds-matured-foreign https://stock.noler.com/us/stock/effector-therapeutics-inc/outstanding-bonds-matured-unclassified https://stock.noler.com/us/stock/effector-therapeutics-inc/outstanding-bonds-unclassified https://stock.noler.com/us/stock/effector-therapeutics-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/effector-therapeutics-inc/paid-in-kind-interest https://stock.noler.com/us/stock/effector-therapeutics-inc/patents https://stock.noler.com/us/stock/effector-therapeutics-inc/patents-active https://stock.noler.com/us/stock/effector-therapeutics-inc/patents-expired https://stock.noler.com/us/stock/effector-therapeutics-inc/patents-pending https://stock.noler.com/us/stock/effector-therapeutics-inc/patents-rejected https://stock.noler.com/us/stock/effector-therapeutics-inc/payables-and-obligations https://stock.noler.com/us/stock/effector-therapeutics-inc/payments-for-proceeds-from-productive-assets https://stock.noler.com/us/stock/effector-therapeutics-inc/payments-for-rent https://stock.noler.com/us/stock/effector-therapeutics-inc/payments-of-debt-extinguishment-costs https://stock.noler.com/us/stock/effector-therapeutics-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/effector-therapeutics-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/effector-therapeutics-inc/payments-to-acquire-productive-assets https://stock.noler.com/us/stock/effector-therapeutics-inc/payments-to-acquire-restricted-investments https://stock.noler.com/us/stock/effector-therapeutics-inc/payments-to-acquire-short-term-investments https://stock.noler.com/us/stock/effector-therapeutics-inc/pb-ratio https://stock.noler.com/us/stock/effector-therapeutics-inc/pe-ratio https://stock.noler.com/us/stock/effector-therapeutics-inc/preferred-shares https://stock.noler.com/us/stock/effector-therapeutics-inc/preferred-shares-facts https://stock.noler.com/us/stock/effector-therapeutics-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/effector-therapeutics-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/effector-therapeutics-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/effector-therapeutics-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/effector-therapeutics-inc/preferred-stock-value https://stock.noler.com/us/stock/effector-therapeutics-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/effector-therapeutics-inc/prepaid-expense-current https://stock.noler.com/us/stock/effector-therapeutics-inc/pretax-income https://stock.noler.com/us/stock/effector-therapeutics-inc/proceeds-from-debt-net-of-issuance-costs https://stock.noler.com/us/stock/effector-therapeutics-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/effector-therapeutics-inc/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/effector-therapeutics-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/effector-therapeutics-inc/proceeds-from-sale-of-short-term-investments https://stock.noler.com/us/stock/effector-therapeutics-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/effector-therapeutics-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/effector-therapeutics-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/effector-therapeutics-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/effector-therapeutics-inc/property-plant-equipment https://stock.noler.com/us/stock/effector-therapeutics-inc/ps-ratio https://stock.noler.com/us/stock/effector-therapeutics-inc/public-float https://stock.noler.com/us/stock/effector-therapeutics-inc/quick-ratio https://stock.noler.com/us/stock/effector-therapeutics-inc/recapitalization-costs https://stock.noler.com/us/stock/effector-therapeutics-inc/reddit https://stock.noler.com/us/stock/effector-therapeutics-inc/repayments-of-related-party-debt https://stock.noler.com/us/stock/effector-therapeutics-inc/research-and-development https://stock.noler.com/us/stock/effector-therapeutics-inc/retained-earnings https://stock.noler.com/us/stock/effector-therapeutics-inc/revenue https://stock.noler.com/us/stock/effector-therapeutics-inc/revenue-from-contract-with-customer-including-assessed-tax https://stock.noler.com/us/stock/effector-therapeutics-inc/revenue-remaining-performance-obligation https://stock.noler.com/us/stock/effector-therapeutics-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/effector-therapeutics-inc/sale-of-stock-percentage-of-ownership-after-transaction https://stock.noler.com/us/stock/effector-therapeutics-inc/sec-comment-letters https://stock.noler.com/us/stock/effector-therapeutics-inc/sec-enforcement-actions https://stock.noler.com/us/stock/effector-therapeutics-inc/sec-filings https://stock.noler.com/us/stock/effector-therapeutics-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-lower-range-limit https://stock.noler.com/us/stock/effector-therapeutics-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-upper-range-limit https://stock.noler.com/us/stock/effector-therapeutics-inc/share-based-goods-and-nonemployee-services-transaction-stockholders-equity https://stock.noler.com/us/stock/effector-therapeutics-inc/share-buybacks https://stock.noler.com/us/stock/effector-therapeutics-inc/share-price https://stock.noler.com/us/stock/effector-therapeutics-inc/shareholder-equity https://stock.noler.com/us/stock/effector-therapeutics-inc/shareholders-equity https://stock.noler.com/us/stock/effector-therapeutics-inc/shares-authorized https://stock.noler.com/us/stock/effector-therapeutics-inc/shares-issued https://stock.noler.com/us/stock/effector-therapeutics-inc/shares-issued-for-acquisitions https://stock.noler.com/us/stock/effector-therapeutics-inc/shares-outstanding-analysis https://stock.noler.com/us/stock/effector-therapeutics-inc/short-interest https://stock.noler.com/us/stock/effector-therapeutics-inc/short-sale-volume https://stock.noler.com/us/stock/effector-therapeutics-inc/short-term-investments https://stock.noler.com/us/stock/effector-therapeutics-inc/spending-and-interest-coverage https://stock.noler.com/us/stock/effector-therapeutics-inc/stock-and-warrants-issued-value-preferred-stock-and-warrants https://stock.noler.com/us/stock/effector-therapeutics-inc/stock-award-award-vesting-rights-percentage https://stock.noler.com/us/stock/effector-therapeutics-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/effector-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/effector-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate-maximum https://stock.noler.com/us/stock/effector-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate-minimum https://stock.noler.com/us/stock/effector-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/effector-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-maximum https://stock.noler.com/us/stock/effector-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-minimum https://stock.noler.com/us/stock/effector-therapeutics-inc/stock-award-number-of-shares-authorized https://stock.noler.com/us/stock/effector-therapeutics-inc/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/effector-therapeutics-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/effector-therapeutics-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/effector-therapeutics-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/effector-therapeutics-inc/stock-based-compensation https://stock.noler.com/us/stock/effector-therapeutics-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/effector-therapeutics-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/effector-therapeutics-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/effector-therapeutics-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/effector-therapeutics-inc/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/effector-therapeutics-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/effector-therapeutics-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/effector-therapeutics-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/effector-therapeutics-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/effector-therapeutics-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/effector-therapeutics-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/effector-therapeutics-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/effector-therapeutics-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/effector-therapeutics-inc/stock-options-nonvested-number-of-shares https://stock.noler.com/us/stock/effector-therapeutics-inc/stock-options-nonvested-options-forfeited-number-of-shares https://stock.noler.com/us/stock/effector-therapeutics-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/effector-therapeutics-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/effector-therapeutics-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/effector-therapeutics-inc/stock-options-vested-and-expected-to-vest-exercisable-aggregate-intrinsic-value https://stock.noler.com/us/stock/effector-therapeutics-inc/stock-options-vested-and-expected-to-vest-exercisable-average-exercise-price https://stock.noler.com/us/stock/effector-therapeutics-inc/stock-options-vested-and-expected-to-vest-exercisable-number https://stock.noler.com/us/stock/effector-therapeutics-inc/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/effector-therapeutics-inc/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/effector-therapeutics-inc/subsidiaries https://stock.noler.com/us/stock/effector-therapeutics-inc/supplier-breakdown https://stock.noler.com/us/stock/effector-therapeutics-inc/tax-reconciliation-tax-credits-research https://stock.noler.com/us/stock/effector-therapeutics-inc/taxes-payable-current https://stock.noler.com/us/stock/effector-therapeutics-inc/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/effector-therapeutics-inc/temporary-equity-liquidation-preference https://stock.noler.com/us/stock/effector-therapeutics-inc/temporary-equity-shares-authorized https://stock.noler.com/us/stock/effector-therapeutics-inc/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/effector-therapeutics-inc/total-assets https://stock.noler.com/us/stock/effector-therapeutics-inc/total-contract-liability https://stock.noler.com/us/stock/effector-therapeutics-inc/total-liabilities https://stock.noler.com/us/stock/effector-therapeutics-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/effector-therapeutics-inc/total-long-term-debt https://stock.noler.com/us/stock/effector-therapeutics-inc/unamortized-debt-issuance-expense https://stock.noler.com/us/stock/effector-therapeutics-inc/undistributed-earnings-loss-allocated-to-participating-securities-basic https://stock.noler.com/us/stock/effector-therapeutics-inc/undistributed-earnings-loss-available-to-common-shareholders-diluted https://stock.noler.com/us/stock/effector-therapeutics-inc/unrealized-gain-loss-on-investments https://stock.noler.com/us/stock/effector-therapeutics-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/effector-therapeutics-inc/utb-change https://stock.noler.com/us/stock/effector-therapeutics-inc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/effector-therapeutics-inc/utb-income-tax-penalties-and-interest-expense https://stock.noler.com/us/stock/effector-therapeutics-inc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/effector-therapeutics-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/effector-therapeutics-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/effector-therapeutics-inc/voting-outcome https://stock.noler.com/us/stock/effector-therapeutics-inc/warrants-and-rights-outstanding https://stock.noler.com/us/stock/effector-therapeutics-inc/workers-compensation-liability-current https://stock.noler.com/us/stock/effector-therapeutics-inc/youtube